1. Home
  2. MIST vs LEE Comparison

MIST vs LEE Comparison

Compare MIST & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • LEE
  • Stock Information
  • Founded
  • MIST 2003
  • LEE 1890
  • Country
  • MIST Canada
  • LEE United States
  • Employees
  • MIST N/A
  • LEE N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • MIST Health Care
  • LEE Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • LEE Nasdaq
  • Market Cap
  • MIST 89.8M
  • LEE 38.2M
  • IPO Year
  • MIST N/A
  • LEE N/A
  • Fundamental
  • Price
  • MIST $1.92
  • LEE $6.32
  • Analyst Decision
  • MIST Strong Buy
  • LEE
  • Analyst Count
  • MIST 2
  • LEE 0
  • Target Price
  • MIST $7.50
  • LEE N/A
  • AVG Volume (30 Days)
  • MIST 613.1K
  • LEE 36.5K
  • Earning Date
  • MIST 08-07-2025
  • LEE 07-31-2025
  • Dividend Yield
  • MIST N/A
  • LEE N/A
  • EPS Growth
  • MIST N/A
  • LEE N/A
  • EPS
  • MIST N/A
  • LEE N/A
  • Revenue
  • MIST N/A
  • LEE $591,094,000.00
  • Revenue This Year
  • MIST N/A
  • LEE N/A
  • Revenue Next Year
  • MIST N/A
  • LEE N/A
  • P/E Ratio
  • MIST N/A
  • LEE N/A
  • Revenue Growth
  • MIST N/A
  • LEE N/A
  • 52 Week Low
  • MIST $0.63
  • LEE $5.83
  • 52 Week High
  • MIST $2.75
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • MIST 67.01
  • LEE 47.62
  • Support Level
  • MIST $1.85
  • LEE $5.83
  • Resistance Level
  • MIST $2.02
  • LEE $6.72
  • Average True Range (ATR)
  • MIST 0.09
  • LEE 0.38
  • MACD
  • MIST 0.01
  • LEE 0.07
  • Stochastic Oscillator
  • MIST 73.75
  • LEE 71.37

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: